0000899243-19-000518.txt : 20190104 0000899243-19-000518.hdr.sgml : 20190104 20190104161055 ACCESSION NUMBER: 0000899243-19-000518 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190102 FILED AS OF DATE: 20190104 DATE AS OF CHANGE: 20190104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Erlander Mark CENTRAL INDEX KEY: 0001651537 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35558 FILM NUMBER: 19510132 MAIL ADDRESS: STREET 1: C/O TROVAGENE, INC. STREET 2: 11055 FLINTKOTE AVENUE, SUITE A CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Trovagene, Inc. CENTRAL INDEX KEY: 0001213037 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043721895 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11055 FLINTKOTE AVENUE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-217-5420 MAIL ADDRESS: STREET 1: 11055 FLINTKOTE AVENUE CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: TrovaGene Inc. DATE OF NAME CHANGE: 20110830 FORMER COMPANY: FORMER CONFORMED NAME: XENOMICS INC DATE OF NAME CHANGE: 20040719 FORMER COMPANY: FORMER CONFORMED NAME: USED KAR PARTS INC DATE OF NAME CHANGE: 20030106 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-01-02 0 0001213037 Trovagene, Inc. TROV 0001651537 Erlander Mark C/O TROVAGENE, INC. 11055 FLINTKOTE SAN DIEGO CA 92121 0 1 0 0 Chief Scientific Officer Common Stock 2019-01-02 4 M 0 1563 0.00 A 19708 D Common Stock 2019-01-02 4 F 0 698 0.00 D 19010 D Restricted Stock Units 2019-01-02 4 M 0 1563 0.00 D Common Stock 1563 33125 D Represents the conversion upon vesting of restricted stock units into common stock (the "Converted Common Stock"). On January 4, 2017, the reporting person was granted 6,250 restricted stock units, 1,563 of which vested on January 2, 2019. Such restricted stock units were previously reported in Table II on a Form 4 filed with the Securities and Exchange Commission on January 4, 2017. The reporting person is reporting the withholding by Trovagene, Inc. of 698 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of the Converted Common Stock to the reporting person on January 2, 2019. Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock. On January 4,2017, the reporting person was granted 6,250 restricted stock units, 1,563 of which vested on January 2, 2019. The common stock into which such vested restricted stock units converted on January 2, 2019 is reported in Table I on this Form 4. /s/ Mark Erlander 2019-01-04